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1. Introduction
Human dipeptidyl peptidase IV (hDPPIV/CD26, EC 
3.4.14.5) is a member of the type II transmembrane serine 
proteases that cleave the N-terminal dipeptides X-Pro or 
X-Ala from target polypeptidase, such as peptide hormones 
and chemokines. DPPIV is expressed in microbial and 
insect cells and nearly all mammalian tissues (Cunningham 
and O’Connor, 1997), and it plays important roles in 
the gastrointestinal, neurological, endocrinological, 
and immunological systems (Demuth and Heins, 1995; 
Bergmann and Bohuon, 2002; Thoma et al., 2003; Pérez-
Guzmán et al., 2004). This enzyme regulates blood 
sugar levels and overexpresses in cancer cells and tumor 
progression in several human malignancies; in addition, 
lack of the enzyme reportedly causes autoimmune diseases 
(Reichelt et al., 1981; Shattock et al., 1990; Iwaki-Egawa 
et al., 1998; Langford, 2000; Bergmann and Bohuon, 
2002; Lambeir et al., 2002; Reichelt and Knisberg, 2003; 
Aertgeerts et al., 2004; Urade et al., 2006).
 Currently, DPPIV is widely used as an important 
compound in commercial digestive enzymes to support 
patients who lack the hydrolysis enzyme (Üstün and 
Öngen, 2012). Studies have shown that bacterial 
production of DPPIV is the most economical method 
due to the short incubation periods required, such as 4–6 
h in submerged culture (Zevaco et al., 1990; Lloyd and 
Pritchard, 1991; Tachi et al., 1992; Wilkinson and Houston, 
2001; Ota et al., 2005; Üstün and Öngen, 2012). However, 
certain portions of the enzyme expressed in prokaryotes 
may be of limited use in human metabolism due to the 
potential for improper posttranslational modifications. 
Therefore, Aspergillus strains are commonly preferred 
for the commercial production of extracellular DPPIV 
in the dietary supplement market (Tachi et al., 1992; 
Doumas et al., 1998; Öngen et al., 2012). In addition to 
fungi, mammalian cells and insect cells also offer feasible 
eukaryotic hosts for dietary supplement production. 
Insect cell and baculovirus expressions are known to 
be industrially useful systems for recombinant protein 
production. Certain technological advances are much 
easier to culture in animal cells due to their higher 
tolerance for osmolality, by-product concentrations, 
proper posttranslational modifications, and higher 
expression levels (Ikonomou et al., 2003). Additionally, 
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insect cells can easily adapt to industrial media from 
adherent to suspension cultures in shake flasks and 
bioreactors (Jianyong et al., 1990). 
Most related studies have focused on expression, 
characterization, and purification techniques to determine 
the biological structure of hDPPIV/CD26 using various 
small-scale resources, such as T-flask or shake-flask 
cultures (Yamaji et al., 1999; Dobers et al., 2002; Carmo 
et al., 2012). Rice et al. (1993) reported that a stirred-
vessel fermenter could be an alternative recombinant 
protein production system for Sf9 cell growth and protein 
expression levels. In this study, the production of an Sf9 
insect cell line from a T-flask to a 3-L stirred fermenter 
and the expression of recombinant hDPPIV/CD26 were 
examined in serum-added medium to protect the cell line 
against the detrimental effects of shear stress. 
Determination of the optimal viral titer is critical 
for achieving a high expression level and productivity 
in a recombinant protein. Therefore, in traditional batch 
fermentation processes high multiplicity of infection 
(MOI) values for the two scaling-up processes should be 
considered: one for the cell and one for the virus. However, 
low-MOI strategies lead to the preservation of the genetic 
integrity of a virus due to the low passage effects. In the 
present study, our low-MOI strategy was examined for 
high expression and productivity of hDPPIV/CD26 from 
Sf9 cells in 1.5-L and 3-L fermenters. 
Oxygen consumption, cell viability, and enzyme 
expression were monitored in a stirred-tank fermenter, 
which is traditionally preferred in industrial production 
due to the low economic and design demands involved. 
Agitation rates, aeration rates, and shear stress were 
determined for the Sf9 cells.
2. Materials and methods
2.1. Materials
The Spodoptera frugiperda cell line (Sf9), pFastBac1 
transfer vector, competent DH10Bac Escherichia coli 
cells, Sf-900 II SFM, Cellfectin II, and antibiotics were 
purchased from Invitrogen, Gibco BRL. Bluo-Gal, IPTG, 
protease inhibitor mix, and EX-CELL 420 medium were 
obtained from Sigma.
2.2. Plasmid construction, transfection of bacmid 
DNA into Sf9 cells, and amplification of recombinant 
baculovirus
The full-length cDNA of hDPPIV/CD26 was obtained from 
pEBFP-N1-DPP IV (University of Magdeburg, Germany), 
and all routine restriction enzyme digestion and ligation 
was performed into the cloning site of pFastBac1 (Gibco 
BRL) vector (Üstün-Aytekin et al., 2014). The recombinant 
plasmid was transformed from pFastBac1 to E. coli 
DH10Bac, and bacmid DNA was extracted by HiSpeed 
Plasmid Maxi kit (Qiagen, Germany). Monolayers of Sf9 
cells (9 × 105 cells per well in a 6-well plate) were transfected 
with purified bacmid-DNA using the Cellfectin II reagent 
(Gibco BRL). The recombinant virus was amplified twice 
to obtain higher titered virus stocks and then harvested. 
Virus titers were determined by plaque assay (Celis et al., 
2005). 
2.2.1. hDPPIV/CD26 protein expression and preparation 
of baculovirus-infected cell stocks
Sf9 cells in 6-well plates [Sf-900 II SFM, 10% v/v heat-
inactivated fetal bovine serum (FBS, Biochrome, 
Germany) and 50 μg mL–1 w/v, gentamicin] were infected 
with recombinant viruses at MOI values of 0.1 using the 
harvest time (72 h) reported in our previous study (Üstün-
Aytekin et al., 2014). Infected cells (1 × 107 cells) were 
cryopreserved as baculovirus-infected cell stocks and 
stored at –86 °C (Wasilko and Lee, 2006). The infected cells 
(1 × 106 viable cells) were quickly thawed and inoculated 
into the fermenter (Wasilko et al., 2009). 
2.3. Disruption of infected Sf9 cells
The infected cells were washed three times with phosphate-
buffered saline (PBS) and then resuspended on ice in 300 
µL of lysis buffer [20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 
10% (w/v) glycerol, IPEGAL CA-630] for 9 × 105 cells mL–
1. Samples were centrifuged for 10 min at 12,000 × g at 4 
°C after sonication (three 20-s pulses with the Bandelin 
model, 45% power). The supernatants were examined for 
hDPPIV/CD26 activities and protein amounts or stored at 
–20 °C until further use.
2.4. Determination of protein concentration, enzymatic 
activity, and electrophoretic mobility of proteins
The protein concentrations were assayed using the BCA 
Protein Assay Reagent kit (Pierce). Enzymatic activity 
was determined with Gly-Pro-p-nitroanilide as the 
substrate. The amount of the enzyme producing 1 µmol 
p-nitroaniline per minute was defined as the unit of 
enzyme. The production samples were analyzed by SDS-
PAGE according to the method of Laemmli (1970). 
Molecular weight marker proteins (molecular weight 
standard 10–250 kDa; Fermentas, Canada) were used as 
references.
2.5. Monitoring hDPPIV/CD26 expression with 
immunofluorescence method
The fluorescence method was used to detect the location 
and relative abundance of the hDPPIV/CD26 enzyme. 
CD26 rabbit polyclonal antibody (CD 26-H270: sc-9153; 
Santa Cruz, USA) was used as the primary antibody, and 
goat anti-rabbit (594; Invitrogen, UK) was the secondary 
antibody. The cells were fixed to coverslips and washed 
three times in 500 µL of PBS for 5 min, 1 mL of blocking 
solution (PBS/triton X-100) was added, and the cells were 
incubated for 1 h at room temperature. The cells were 
resuspended in 50 µL of primer antibody (PBS/triton 
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X-100, 1:100) overnight at 4 °C. After washing three times 
in PBS, the cells were resuspended in secondary antibody 
(PBS/triton X-100, 1:750) for 2 h at room temperature. 
The cells were exposed to an appropriate amount of 
4’,6-diamidino-2-phenylindole for 20 min and washed 
three times in PBS. The cover slips were sealed with 
paraffin and the labeled cell preparations were examined 
with a Leica DM IL LED (Germany) confocal microscope.
2.6. Adaptation of Sf9 cells to EX-CELL 420 medium
Because uninfected Sf9 cells are not able to adapt directly 
from adherent culture media into new media designed 
for use in large scale production, the growth medium was 
gradually switched from Sf-900 II SFM [10% v/v, heat-
inactivated FBS, and gentamicin (w/v, 50 μg mL–1)] to EX-
CELL 420 medium [10% v/v, heat-inactivated FBS, and 
gentamicin (w/v, 50 μg mL–1)] to prepare the adherent Sf9 
cell culture in T-flasks. Sf-900 II SFM-adapted cell lines 
were maintained in approximately 75% Sf-900 II SFM and 
25% EX-CELL 420 for two passages. Next, the medium was 
replaced with approximately 50% Sf-900 II SFM and 50% 
EX-CELL 420 for two passages. In the last step, the medium 
was replaced with approximately 25% Sf-900 II SFM and 
approximately 75% EX-CELL 420. Finally, the 100% used 
in industrial production was attained. The morphology 
of the cell lines was monitored under an inverse phase 
microscope after each medium replacement (Figure 1). 
Although the preferred media have been formulated as 
serum free, FBS (10% v/v, heat-inactivated) was added to 
protect the cells against the hydrodynamically lethal effect 
from Rushton turbines. 
2.7. Inoculum preparation
After adapting the uninfected Sf9 cells to EX-CELL 420 
medium, the cells were routinely maintained in 125-mL 
shake flasks at a working volume of 20 mL of EX-CELL 
420 [10% v/v heat-inactivated FBS and gentamicin (w/v, 
50 µg mL–1)] at 27 °C and then agitated at 90 rpm. The 
cell densities were determined using a hemocytometer, 
and the viability was determined by the trypan blue dye 
exclusion method. 
These pre-adapted cells were subcultured to 4–5 × 105 
viable cells mL–1 after reaching 1 × 106 cells mL–1 in 20 mL 
of EX-CELL 420 medium.
2.8. Fermenter conditions and Sf9 cell line propagation 
A stirred-tank bench top microbial fermenter (5 L; 
Sartorius Stedim, Biostat B, Germany) was used in batch 
mode to express hDPPIV/CD26 in the Sf9 cells. The 
fermenter, which was constructed of glass and equipped 
with Rushton type impellers, was run first at a working 
volume of 1.5 L and then at 3 L. The fermenter containing 
distilled water was autoclaved at 15 psig and 121 °C for 45 
min. 
The dissolved oxygen (DO) concentration was 
monitored during production to determine oxygen 
consumption. The medium used in the fermenter 
cultures was EX-CELL 420, supplemented with FBS and 
gentamicin. The fermenter was seeded with exponentially 
growing cells at an initial concentration of 4–5 × 105 viable 
cells mL–1 from the shake flask cultures under sterile 
conditions. The cultures were infected with baculovirus-
infected cell stocks (MOI of 0.1) when the cells reached a 
level of 1 × 106 viable cells mL–1 in the fermenter.
During this process, as well as before and after infection, 
the fermenter was monitored for pH, cell viability, hDPPIV/
CD26 activity, and the amount of protein, in addition to 
oxygen consumption. Therefore, culture samples were taken 
at regular intervals from the fermenter and centrifuged. The 
cell pellets were resuspended in a lysis buffer, disrupted, 
and centrifuged. After centrifugation, the clear supernatant 
samples were stored at –20 °C for subsequent analysis. 
2.9. Strategies of production in microbial fermenter 
Aeration rate (Q), specific death rate) (kd), agitation rate 
(N), and shear stress (t) were considered when scaling up 
from the flask to the 1.5-L-working-volume fermenter. 
Calculation steps were estimated for every rotational 
speed of the impeller from 40 to 100 rpm, and one was 
selected based on its possible shear stress for 1.5 L and 3 L 
scale production (Aiba et al., 1973; Doran, 1995; Wu and 
Goosen, 1995; Tramper et al., 1996). 
The scale-up of production was designed with the 
oxygen mass transfer coefficient (kLa) principle. The 
production of Sf9 cells was monitored for oxygen transfer 
rate (OTR), oxygen uptake rate (OUR), specific oxygen 
consumption rate (qO2), and  kLa by ensuring optimal 
rotational speeds of the impeller and optimal aeration 
rates at a working volume of 1.5 L for 15 days. The specific 
oxygen consumption rate (qO2) was determined by 
following the amount of dissolved oxygen in the medium 
when the gas supply to the fermenter was turned off; thus, 
qO2 can be calculated as follows (Gomez et al., 2006): 
dt
d q C OURC x02= = .                                                     (1)
In Eq. (1),  is the biomass concentration (cell mL–1), and 
dC/dt is the accumulation of oxygen in the liquid phase. 
The dissolved oxygen concentration gradually increased 
up to a constant value after aeration was restarted, and kLa 
was determined with the estimated OUR value. Oxygen 
transfer is usually limited by the liquid film surrounding 
the gas bubbles. The rate of transport is given by the 
following equation:
 
( )dt
dC OTR OUR k a C C*L L L= - = - ,                                   (2)
where kL is the oxygen transport coefficient (cm h
–1), a is 
the gas-liquid interfacial area (cm2 cm–3),  the oxygen mass 
transfer coefficient (h–1),  the saturated DO concentration 
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(mg mL–1) (approx. 8 mg mL–1 at 25 °C and 1 atm), and 
is the actual DO concentration in the liquid (mg mL–1) 
(Bailey and Ollis, 1986). The value was kept constant 
during production from the 1.5 L fermenter to the 3 L 
fermenter [Eq. (3)] by considering the OTR and OUR in 
the 1.5 L fermenter:
( )k a x V
P u2 10 . .L G3 0 7 0 2–= .                                                  (3)
2.10. Separation steps for recombinant hDPPIV/CD26
Samples were taken daily from the fermenter and 
centrifuged at 100 × g for 5 min at 4 °C using the Sigma 
3K30 (Newtown, UK). Then samples were washed three 
times with PBS and centrifuged under the same conditions. 
After removing the supernatant, the cells were disrupted 
by sonication in lysis buffer and centrifuged at 12,000 × 
g for 10 min. The crude cell extract was applied to the ion 
exchange column (Hiprep 16/10 QFF, GE Healthcare) 
and equilibrated with 100 mM Tris–HCl (pH 9.0) buffer. 
Proteins were eluted at 1 mL min–1, applying an initial 
isocratic step to the equilibration buffer, followed by a 
linear gradient from 0 to 2 M NaCl. The eluate was collected 
in 4-mL fractions. The active samples were applied to a 
Sephacryl 300 HR column (GE Healthcare), which is a 
molecular size exclusion column, and equilibrated with 
100 mM Tris–HCl (pH 9.0). The proteins were eluted at 0.3 
mL min–1, and 5-mL fractions were collected and stored at 
–20 °C until further use.
3. Results 
3.1. Production in microbial fermenter: adaptation of 
Sf9 cells to the industrial media and propagation of the 
cells in shake flasks
The nonadapted cell lines evolved into a polymorphic 
shape; the cells lost their adherent ability after direct 
replacement with EX-CELL 420 (Figure 1). Infection 
of these nonadapted cells (Figure 1) may affect gene 
expression and cell growth kinetics. Therefore, the 
adaptation of the cells in the new medium and cell 
maintenance must be accomplished before large scale 
production. As shown in Figure 1b, the cells were attached 
firmly to the T-flask surface; the size of the cells was 
small and regular. Progressive adaptation of Sf9 cells was 
successfully achieved.
3.2. Production strategies in the microbial fermenter: 
calculation of bubble size, specific death rate, and 
aeration rate 
In the present study, the injected bubble size ( from the 
ring sparger to the fermenter was calculated as 3.5 mm 
according to Doran (1995).  and  were calculated and 
examined considering the recommended aeration range 
0.005–0.007 vvm in sparged bioreactors, according to 
Jöbses et al. (1991) and Doran (1995). The  values were 
calculated as  = 2.20 × 10–7 s–1 (0.005 vvm) and = 8.81 
× 10–7 s–1 (0.03 vvm) for the 1.5-L and 3-L fermenters, 
respectively, in the present study.
Sparging-associated damages can be enhanced by 
impeller agitation. Therefore, other hydrodynamic forces, 
including agitation rate and shear stress values, were also 
calculated.
3.3. Production strategies in the fermenters: 
dimensionless numbers, shear stress, and agitation rate 
Dimensionless numbers and some hydrodynamic 
parameters related to the viscosity and density in the 1.5-
L fermenter are given in Table 1. The impeller Reynolds 
number indicated that the flow regime was turbulent 
in the stirred-tank fermenter. Power number (Pno) was 
5 according to the graph of Aiba et al. (1973), which 
represents the power number versus the Reynolds number 
for Rushton turbine geometry. There has been a significant 
connection between sparged gas and power consumption 
in the aerated fermenter. The gassed power consumption 
(a)                                                                                                  (b)                               
100 m 100 m 
Figure 1. a) Nonadapted Sf9 cells from Sf-900 II SFM to EX-CELL 420, b) Sf9 cells pre-adapted to 
EX-CELL 420 (20×; Olympus, Japan).
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decreased (Pg), as the sparged gas bubbles reduced the 
liquid density in the aerated fermenters (Hensirisak et 
al., 2002). Pg is a function used to calculate the empirical 
mass average of turbulent energy dissipation (ε) based on 
the energy dissipation equality; ε was used to calculate 
maximum shear stress (τmax) (Table 2).
3.4. Monitoring Sf9 cell propagation and hDPPIV 
expression in fermenters
The adapted uninfected Sf9 cells with EX-CELL 420 were 
inoculated into the 1.5-L working volume and treated 
with baculovirus-infected cell stocks (MOI of 0.1) when 
the concentration of cultured Sf9 cells reached 8 × 105 cell 
mL–1. The hDPPIV activity and percent cell viabilities are 
shown in Figure 2. The doubling time of the uninfected 
cells was 26 h, and the specific growth rate was 0.026 
h–1 in the fermenter. After infection at 48 h, the Sf9 cells 
grew gradually up to 96 h, followed by a significant 
decrease until the number of infected cells was attained 
in a stable stationary phase. The expression of hDPPIV/
CD26 increased 39-fold over the same period. The amount 
of protein in the same samples was 7 mg mL–1 and 9 mg 
mL–1 at 24 h and 144 h, respectively. Viable cell counts 
and the amount of expressed hDPPIV/CD26 had opposite 
correlations until 168 h postinfection, at which point both 
had reached a steady state. Therefore, the expression of 
recombinant hDPPIV/CD26 (575.49 mU mL–1 ± 28.7) 
from infected cells was thought to remain stable, despite 
the passage of time and formation of by-products. 
The propagation of Sf9 cells was achieved by 
maintaining a constant  when increasing the volume from 
1.5 L to 3 L. The doubling time of uninfected cells was 51 
h, and the specific growth rate was 0.01 h –1. 
As shown in Figure 2, the increasing expression of 
hDPPIV/CD26 activity and the decreasing cell viability 
of infected Sf9 cells in the 3-L reaction had similar 
propensities in the 1.5-L reaction. Cell count became 5 
× 104 cells mL–1 after 216 h and 312 h in 1.5-L and 3-L 
fermentation, respectively. The time difference between 
these productions were due to the restrictions resulting 
from agitation and aeration rates. As mentioned above, 
the agitation rate can be adjusted to a maximum 60 rpm, 
and aeration was adjusted for kLa, which should be same in 
both productions. However, due to Vk and the shear effect 
there was also a limitation for aeration. The expression 
of hDPPIV/CD26 (639.25 mU mL–1 ± 30.95) increased 
slightly at 216 h postinfection and then remained constant 
up to the end of production in the 3-L fermenter. hDPPIV/
CD26 was 29-fold higher at 360 h than at 0 h, while the 
protein amounts of the samples were 6.42 mg mL–1 and 
6.24 mg mL–1 at 0 h and 216 h, respectively.
The expression of hDPPIV/CD26 was supported 
by SDS-PAGE in Figure 3. The density of the expressed 
hDPPIV/CD26 bands on SDS-PAGE supported the 
amount of hDPPIV activity from infected Sf9 cells in both 
the 1.5-L and 3-L preparations. The molecular weight of 
hDPPIV was measured taking into consideration the 
electrophoretic mobility of proteins and markers on the 
gel and was approximately 70 kDa (69.19 kDa).
Table 1. Dimensionless numbers and some hydrodynamic 
parameters in the 1.5-L fermenter. 
Total volume (L) 5
Operating volume (L) 1.5
µ (kg m–1 s–1) 1.122 × 10–3
ϑ (m2 s–1) 1.1 × 10–6
Rei 3272
Pno 5
Na 5 × 10
–4
Pg/P 0.95
Table 2. Possible shear stresses at increasing agitation rates in the EX-CELL 420 medium.
Agitation rates
40 rpm 50 rpm 60 rpm 70 rpm 80 rpm 90 rpm 100 rpm
Pg (
kgm
s
2
3 ) 0.0010 0.0021 0.0037 0.0059 0.0095 0.0128 0.0173
ε ( m
s
2
3 ) 0.0047 0.0095 0.0168 0.0267 0.0432 0.0583 0.0790
 
τmax (
N
m2
) 0.39 0.55 0.73 0.93 1.18 1.37 1.60
AYTEKİN et al.  / Turk J Biol
222
3.5. Oxygen consumption in the 1.5-L and 3-L 
productions
Varying states of oxygen consumption among the 
uninfected and infected Sf9 cells were observed (Table 3). 
The oxygen consumption values (OUR and qO2) increased 
approximately 2.4-fold at 72 h postinfection in the 1.5-L 
fermenter. The data from the 3-L fermenter also supported 
this result. 
The scale-up equations were performed to keep kLa 
values constant at the 1.5-L and the 3-L scales. As a result 
of these equations kLa values were 0.0129 min
–1 and 0.0133 
min–1, respectively.
3.6. Infection efficiency and productivity of hDPPIV/
CD26 in the 1.5-L and 3-L reactions
The immunofluorescence results revealed that infection 
efficiency, that is, the percentage of transfected Sf9 
cells in the population, was 78%–81% in the 1.5-L and 
3-L fermenters. Moreover, the ratio of hDPPIV/CD26 
expressing infected cells (Figure 4) to total infected cells 
was 96% at the 1.5-L scale and 90% at the 3-L scale.
The productivity values of the 1.5-L reaction at 120 
h and the 3-L reaction at 216 h were 3.56 mU mL–1 h–1 
(during the first 48 h of cell growth) and 2.98 mU mL–1 
h–1 (during the first 48 h of cell growth), respectively. The 
(a) 
(b) 
Figure 2. Expressed hDPPIV/CD26 activity (●), infection time (black arrow), and viable count of Sf9 cell 
(■) variation with time over a 15-day batch culture in a 1.5-L (a) and 3-L (b) stirred-tank fermenter.
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(a) 
(b) 
DPPIV 
DPPIV 
Figure 3. Analysis of the hDPPIV/CD26 expression of Sf9 cells in fermenters. (a) hDPPIV/CD26 expression from Sf9 
cells in the 1.5-L fermenter, (b) hDPPIV/CD26 expression from Sf9 cells in the 3-L fermenter. Lanes 4 and 8: prestained 
molecular weight markers (Fujifilm, Finepix F 200 EXR, Japan).
Table 3. OTR, OUR, qO2, and hDPPIV activity for infected and uninfected Sf9 cells at two different working volumes (1.5 L and 3 L) in 
the 5-L fermenter.
0 h
(uninfected Sf9 cells)
72 h postinfection
(infected Sf9 cells)
240 h postinfection
(infected Sf9 cells)
qO2 (molO2 cell
–1 s–1)
                       1.5 L        
                          3 L
9.37 × 10–17
11.35 × 10–17
22.6 × 10–17
17.5 × 10–17
22.1 × 10–17
26.5 × 10–17
OUR (mgO2 L
–1 min–1)
                       1.5 L
                         3 L
0.065
0.2181
0.2284
0.3696
0.0213
0.0255
Cell count (cell mL–1)
                      1.5 L
                        3 L 
3.6 × 105
10 × 105
5.25 × 105
11 × 105
0.5 × 105
0.5 × 105
hDPPIV (mU mL–1)
                    1.5 L
                       3 L
23.6
17
427.06
63.08
563.01
631.15
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number of cells infected with recombinant baculovirus at a 
MOI of 0.1 was 0.5–6 × 105 cell mL–1 on these scales.
3.7. Separation processes of recombinant hDPPIV/CD26 
Purification of the expressed hDPPIV/CD26 protein was 
carried out in two chromatographic columns. Infected Sf9 
cells were disrupted and centrifuged, and then the cleared 
lysates were loaded through to the first column (HiPrep 
16/10 QFF), which was an anion exchange column that 
yielded major peaks on the chromatogram (data not 
shown). Recombinant hDPPIV/CD26 was purified as a 
sharp and clear peak from the column. All fractions were 
tested for hDPPIV/CD26 activity, and the fractions with 
high hDPPIV/CD26 activity (22nd fraction) were applied 
to a second column of HiPrep Sephacryl 300 HR (data not 
shown). 
The maximum recombinant hDPPIV/CD26 activity 
was eluted in the 8th fraction from the molecular size 
exclusion column. Further, the eluate was purified from 
the column as a single peak. 
4. Discussion
4.1. Production strategies in the microbial fermenter: 
calculation of bubble size, specific death rate, and 
aeration rate 
A commonly held belief is that the hydrodynamic forces 
(such as shear stress) associated with agitation and 
aeration may be detrimental to animal cells. One of the 
most significant challenges in suspension cultures of 
mammalian and insect cell lines is shear sensitivity, as 
these cell lines are very fragile due to their relatively large 
size and lack of a cell wall (Garcia-Briones and Chalmers, 
1992; Tramper et al., 1996). In particular, when the process 
is conducted in microbial fermenters, hydraulic pressure 
caused by liquid height becomes significant for sensitive 
cells. Therefore, in addition to the proper aeration rate and 
specific death rates in sparged fermenters, determination 
of bubble size is important for growing the cells. Bubbles 
are defined in a fermenter as large or small. Large bubbles 
rise faster and carry fewer attached cells to the surface 
(b) 
     DAPI                                                                                hDPPIV/CD26  
     DAPI                                                                                    hDPPIV/CD26  
20 m 
20 m 
20 m 
20 m 
(a) 
Figure 4. Immunofluorescence images of recombinant hDPPIV/CD26 proteins expressed from Sf9 cells. (a) 
Uninfected cells, (b) baculovirus infected (MOI = 0.1) Sf9 cells at the end of fermenter production (1.5 L), (66X, 
Leica DM IL LED, Germany).
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compared with small bubbles. According to a study on 
hybridoma cells by Handa et al. (1987), small bubbles were 
more detrimental to cells than the larger ones due to their 
high energy dissipation capacity. In the present study, the 
injected bubble size from the ring sparger to the fermenter 
was 3.5 mm, and this bubble size was considered large by 
Bavarian et al. (1991).   
The cell damage of bubble size may differ depending on 
the cell types, and cell damage is affected by hypothetical 
killing volumes [for insect cells in 10% fetal bovine serum 
(FBS) supplemented media, Vk =m3],, and aeration rate 
(Tramper et al., 1996). Wu and Goosen (1995) reported 
that there was an adverse correlation between kLa – kd,  – kd 
height of fluid in fermenters (Db), and – Vk. Eibl et al. (2009) 
reported that the values of  should be low in the bioreactor 
for the protection of cells against aeration rate damage, 
and Chisti (2000) found that the ideal  was 5 × 10–5 s–1 
for insect cells with large bubbles in serum-free medium. 
The  values from the present study are lower than those 
in related studies. Therefore, we clearly see that medium 
with serum showed a significant effect on cell viability in 
the fermenter compared to the literature. Beas-Catena et 
al. (2013) found that cell concentration and growth rates 
of serum-containing medium decreased by about 50%, 
and the viabilities diminished to 83%–84% in serum-
free medium. Serum-free medium may be economically 
feasible, but every cell line may not grow in it.
4.2. Dimensionless numbers, shear stress, and agitation 
rate 
The values of shear stress increased with the agitation 
rate (Table 2). Tramper et al. (1996) indicated that a shear 
stress of approximately 1 N m–2 was the critical value for 
insect cell damage, and Agathos et al. (1996) reported that 
the viability of insect cell cultures decreased with shear 
stresses of 1.5 N m–2 and 3 N m–2 on two different runs. 
Agitation rates (higher than 70 rpm) may have detrimental 
effects in insect cells. In the case of 50 rpm, agitation is 
not sufficient to maintain a uniform distribution of cells in 
the fermenter; instead, a large clump grew at the bottom 
of the fermenter. Therefore, the optimal agitation rate was 
determined at 60 rpm using the 0.005 vvm aeration rate in 
the 1.5-L stirred-tank fermenter.
4.3. Oxygen consumption in 1.5-L and 3-L productions
Oxygen consumption may differ, depending on the cell 
line, and this is a vital parameter for infection processes. 
However, the determined specific oxygen consumption 
rates were similar between insect and mammalian 
cells (Schmid, 1996). As shown in Table 3, the oxygen 
consumption obtained in this work was between 9.37 × 
10–17 mol cell–l s–1 and 11.35 × 10–17 mol cell–l s–1 in the 1.5-
L and 3-L fermenters, respectively. Oxygen consumption 
in insect cells has been reported at 3.5–9.9 × 10–17 mol 
cell–1 s–1 under different conditions (Kioukia et al., 1995). 
This difference arises due to the absence of serum in the 
medium. Reuveny et al. (1992) reported that specific 
OURs (qO2) of the Sf9 cells, varying between the serum-
containing medium (glucose and 10% fetal calf serum) 
and the serum-free medium (ICSF-WB, BioWhittaker), 
were 6.1 × 10–17 mol cell–l s–1 and 12 × 10–17 mol cell–l s–1, 
respectively. This oxygen uptake rate should be sustained 
by elevated aeration rates, which may also affect the growth 
of cell line due to shear stress. 
Most research groups have reported that the oxygen 
demands of insect cells increase after infection, and this 
property may be responsible for differences arising in using 
the wild-type baculovirus expression vectors, MOI values, 
and physiological condition of the cells between the time 
of infection and the period of the infection (Schmid, 1996; 
Palomares and
Ramirez, 1996; Radner et al., 2012). The oxygen 
consumption values (OUR and qO2) in the present study 
supported these related studies. Increased qO2 indicated 
expression of recombinant hDPPIV/CD26 proteins 72 h 
and 240 h postinfection (Table 3). The addition of serum 
to insect cell line medium helps to decrease the level of 
OURs and shear stress. 
In addition to oxygen consumption values, plays 
an important role in maintaining the economy of the 
processes, scaling up, and process design for aerated 
production (Alam and Razalı, 2005). Measured kLa values 
indicate that the theoretical calculations are supported by 
measured data. 
4.4. Monitoring of hDPPIV expression in fermenters
The maximum enzyme activity from the microbial 
fermenters in the present study was 2.37-fold higher 
than in a T-flask (269 mU mL–1 ± 13.45) in a previous 
work (Üstün-Aytekin et al., 2014). Despite the increasing 
expression of recombinant hDPPIV/CD26 activity, the 
similar protein amounts indicated that recombinant 
hDPPIV/CD26 expression was accomplished successfully. 
The molecular weight of the enzyme was consistent 
with the predicted molecular mass from the amino acid 
sequence of hDPPIV/CD26 (2300 bp) (Tanaka et al., 1992; 
Thoma et al., 2003; Üstün-Aytekin et al., 2014). 
4.5. Infection efficiency and productivity of hDPPIV/
CD26 in the fermenters
Two phenomena are critical for the successful and fast 
expression of an animal cell line in a large scale: infection 
efficiency and productivity. Higher infection efficiency 
values (90% and 96% for 1.5 L and 3 L, respectively) of 
recombinant hDPPIV/CD26 were achieved in the present 
study than in related studies in which the infection 
efficiency was approximately 20%–30% of Sf9 and Sf21 cells 
at 72 h (Radner et al., 2012), while Pham et al. (2003) noted 
an infection efficiency at 40%–60%. The high infection 
efficiency and short incubation period contributed to the 
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fast, high-yield recombinant protein production by large-
scale infection of Sf9 cells. 
Previous findings show that the productivity of 
hDPPIV/CD26 in the present study was approximately 
80-fold higher than in related studies, even though the 
lower MOI value (0.1) reported in the published studies 
resulted in a ready procession to infection and production 
(Üstün-Aytekin et al., 2014). Dobers et al. (2002) reported 
productivity of hDPPIV/CD26 expression at 0.019 
mU mL–1 h–1 at 48 h after infection with a recombinant 
baculovirus at a MOI of 0.7. In another work on the 
characterization and evaluation of recombinant DPPIV 
from Spodoptera frugiperda 21, the highest enzyme 
productivity was 0.04 mU mL–1 h–1 from 0.5 × 105 cell 
mL–1 using a MOI of 10 (Hsieh et al., 2011). A different 
study on recombinant human DPP8, which is similar to 
DPPIV, from a Sf9 cell line infected with a MOI of 0.5, had 
productivity of 0.044 mU mL–1 h–1, according to Chen et 
al. (2004). 
This result can be explained by the potential prevention 
of repeated serial passaging in the cell lines by using 
a lower MOI value. Therefore, no sharp decrease was 
observed in recombinant protein production, nor any 
increase in the viral passages. The use of low MOI on a 
large scale may extend the life span of stored viruses due to 
their 100–1000-fold lower consumption of virus inoculum 
per batch. Additionally, it may be possible to infect large 
fermenters directly from a frozen stock (Wasilko and Lee, 
2006; Hsieh et al., 2011). These advantages of using low 
MOI promise the production of recombinant proteins in 
short time frames and with high productivity.
4.6. Separation processes of recombinant hDPPIV/CD26 
The high- and low-molecular-weight contaminants, 
peptides, and amino acids were successfully removed in 
this chromatographic step. The recovery and resulting 
degrees of separation are summarized in Table 4. The 
fractions consisting of recombinant hDPPIV/CD26 were 
purified 445-fold with a yield of 24.6%, with respect to the 
initial culture, and the specific activity was almost 32.47 U 
mg–1. Purification of hDPPIV/CD26 with immunoaffinity 
chromatography was used to overcome the bounding 
problem in cases in which the protein reassembled into a 
predominantly nonphysiological oligomeric form devoid 
of any enzymatic activity after elution. The reported 
specific activity of hDPPIV/CD26 in insect cells was 28.30 
U mg–1, and the yield was 19.8% (Dobers et al., 2002). These 
differences between activity and yield values are based on 
the utilization of different MOI titers and separation steps.
Cell maintenance and growth of healthy Sf9 cells 
play important roles in the determination of production 
parameters such as hDPPIV/CD26 expression in the 
baculoviral Sf9 cell system, optimal MOI, and infection 
time for the Sf9 cell line. Therefore, the preliminary 
experiment consisted of adapting the cells to a new 
medium (EX-CELL 420) and growing the adapted cells to 
a desired cell density on a small scale. Adapted and healthy 
cells were successfully subcultured and scaled up from a 
working volume of 1.5 L to a working volume of 3 L. It is 
clear that hydrodynamic parameters are crucial in terms 
of production; agitation and aeration without damaging 
shear-sensitive cells, bubble size, or gas consumption are 
difficult to achieve. These factors were determined for the 
Sf9 cell line, and a certain amount of serum was added to 
serum-free medium to decrease shear and stabilize the 
growth of insect cells in a stirred-tank fermenter.
Afterwards, the Sf9 cells were infected with 
baculovirus-infected cell stocks using a low multiplicity 
infection strategy in the fermenter. Thus, the present high 
productivity of hDPPIV/CD26 was derived. The other data 
collected by the study were acquired by monitoring the 
oxygen consumption of infected and uninfected Sf9 cells. 
Oxygen can be used by insect cells to provide energy for 
protein biosynthesis. For this reason, the positive relation 
between oxygen consumption and the level of expressed 
hDPPIV/CD26 was manifested in the present study. 
The products of the gene were isolated using basic 
chromatography techniques. Thus, our use of certain 
production parameters for agitation without damaging 
shear-sensitive insect cells, in addition to sufficient gas 
transfer and expression of a high amount of DPPIV from 
Sf9 cells in a microbial fermenter has proven valuable in 
terms of the goals of the present study. 
Table 4. Separation steps of hDPPIV from baculovirus-infected Sf9 insect cells (100 mL of monolayer culture, 8 × 105 cell mL–1).
Steps Total protein (mg) Total activity(mU)
Specific activity 
(mU mg–1)
Yield
(%)
Purification 
fold
Cell lysate 70 5.100 72.85 100 1
Hiprep 16/10 Q FF 0.125 3.349 26.79 65.66 367
Hiprep 16/60 S 300 HR 0.038 1.255 32.46 24.60 445
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